Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...

US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

If you double up on your dose, it is possible to overdose on Ozempic. Here's what to know—including side effects and what to ...

A new stronger Ozempic is coming. Here’s what to knowNovo Nordisk (NVO) teased some new details about a potential Ozempic ...

The Danish firm’s patents for semaglutide, the active pharmaceutical ingredient in ... According to Novo Nordisk’s website, ...